Fingerprint
Dive into the research topics of 'A randomized phase II trial of the antiangiogenic agent SU5416 in hormone-refractory prostate cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A randomized phase II trial of the antiangiogenic agent SU5416 in hormone-refractory prostate cancer
Walter M. Stadler, Dingcai Cao, Nicholas J. Vogelzang, Christopher W. Ryan, Kristin Hoving, Russell Wright, Theodore Karrison, Everett E. Vokes
Research output: Contribution to journal › Article › peer-review
86
Scopus
citations